Urinary proteomics in kidney and cardiovascular disease
Saved in:
Other Authors: | |
---|---|
Format: | Electronic Video |
Language: | English |
Published: |
London :
Henry Stewart Talks,
2013.
|
Series: | Henry Stewart talks. Biomedical & life sciences collection. Clinical proteomics.
Henry Stewart talks. Biomedical & life sciences collection. Kidney in health and disease. |
Subjects: | |
Online Access: | https://hstalks.com/bs/2678/ Series (Clinical proteomics) Series (Kidney in health and disease) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000ngm a2200000 a 4500 | ||
---|---|---|---|
001 | HST3639 | ||
003 | UkLoHST | ||
006 | m c | ||
007 | cr|cna|||a|||| | ||
007 | vz|czazum | ||
008 | 140117s2013 enk|||||||||||s|||v|eng d | ||
028 | 5 | 0 | |a 3639 |b Henry Stewart Talks |
035 | |a (UkLoHST)2678 | ||
040 | |a UkLoHST |b eng |c UkLoHST | ||
100 | 1 | |a Mischak, Harald, |u (University of Glasgow, UK) |4 spk |9 104982 | |
245 | 1 | 0 | |a Urinary proteomics in kidney and cardiovascular disease |h [electronic resource] / |c Harald Mischak. |
260 | |a London : |b Henry Stewart Talks, |c 2013. | ||
300 | |a 1 online resource (1 streaming video file (53 min.) : |b color, sound). | ||
490 | 1 | |a Clinical proteomics, |x 2056-452X | |
490 | 1 | |a The kidney in health and disease, |x 2056-452X | |
500 | |a Animated audio-visual presentation with synchronized narration. | ||
500 | |a Title from title frames. | ||
505 | 0 | |a Contents: Omics technologies -- Technology platforms: (2DE-MS, LC-MS-MS, CE/MS) -- Clinical proteomics -- Precision as a function of no. of markers -- Human urinary LMW proteome database -- Requirements for biomarker selection -- How to identify valid proteomic biomarkers -- Effect size estimation and the number of samples -- Erroneous biomarkers -- Classification using different sizes of training sets -- Classification errors -- CKD biomarkers -- Biomarker validation -- Pathophysiological suggestions -- Selected urinary peptides and CKD staging -- Multicentric European PRIORITY trial -- Proteomics of coronary artery disease and of diabetic nephropathy. | |
506 | |a Access restricted to subscribers. | ||
538 | |a Mode of access: World Wide Web. | ||
650 | 0 | |a Biochemical markers. |9 104983 | |
650 | 0 | |a Cardiovascular system |x Diseases. |9 104984 | |
650 | 0 | |a Kidneys |x Diseases. |9 104985 | |
650 | 0 | |a Proteomics |x Methodology. |9 104986 | |
650 | 2 | |a Biomarkers. |9 104987 | |
650 | 2 | |a Cardiovascular Diseases. |9 104988 | |
650 | 2 | |a Kidney Diseases. |9 104989 | |
650 | 2 | |a Proteome |x analysis. |9 104990 | |
650 | 2 | |a Proteomics |x methods. |9 104991 | |
830 | 0 | |a Henry Stewart talks. |p Biomedical & life sciences collection. |p Clinical proteomics. |9 104992 | |
830 | 0 | |a Henry Stewart talks. |p Biomedical & life sciences collection. |p Kidney in health and disease. |9 104993 | |
856 | 4 | 0 | |u https://hstalks.com/bs/2678/ |
856 | 4 | 2 | |u https://hstalks.com/bs/p/751/ |3 Series (Clinical proteomics) |
856 | 4 | 2 | |u https://hstalks.com/bs/p/980/ |3 Series (Kidney in health and disease) |
999 | |c 215174 |d 215173 |